Penumbra (PEN) Change in Receivables (2014 - 2026)
Penumbra (PEN) reported Change in Receivables of -$5.5 million for Q1 2026, down 920.63% year-over-year from $675338.0 in Q1 2025, and down 181.21% quarter-over-quarter from $6.8 million in Q4 2025.
Penumbra (PEN) Change in Receivables (2014 - 2026) Analysis & Trends
Penumbra (PEN) has 13 years of Change in Receivables data on file, last reported at -$5.5 million in Q1 2026.
- Change in Receivables for Q1 2026 came in at -$5.5 million, down 920.63% year-over-year; the trailing twelve-month figure through Mar 2026 was $14.5 million (up 177.7% YoY), and the FY2025 annual result was $19.5 million, up 173.37% from the prior year.
- Change in Receivables retreated to -$5.5 million in Q1 2026 per PEN's latest filing, from $6.8 million in the prior quarter.
- Over five years, Change in Receivables peaked at $45.6 million in Q2 2022 and troughed at -$25.4 million in Q3 2024.
- A 5-year average of $3.4 million and a median of $3.5 million in 2023 frame the typical range for Change in Receivables.
- The sharpest annual moves came in 2022 and 2024: Change in Receivables jumped 357.95% in 2022, then slumped 1301.43% in 2024.
- A 5-year view of Change in Receivables shows it stood at $12.5 million in 2022, then tumbled by 150.74% to -$6.3 million in 2023, then surged by 49.05% to -$3.2 million in 2024, then jumped by 311.14% to $6.8 million in 2025, then tumbled by 181.21% to -$5.5 million in 2026.
- Business Quant data shows PEN's Change in Receivables at -$5.5 million in Q1 2026, $6.8 million in Q4 2025, and $8.5 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.92 Bn | 146.27 Bn | 6.27 Bn | 42.00 Mn |
| 2 | Stryker | 119.50 Bn | 116.62 Bn | 3.81 Bn | -444.00 Mn |
| 3 | Medtronic | 102.71 Bn | 94.54 Bn | 5.76 Bn | -13.00 Mn |
| 4 | Boston Scientific | 69.72 Bn | 68.51 Bn | 3.61 Bn | 117.00 Mn |
| 5 | Edwards Lifesciences | 49.24 Bn | 45.57 Bn | 1.29 Bn | 117.90 Mn |
| 6 | GE HealthCare Technologies | 29.74 Bn | 27.67 Bn | 1.98 Bn | -141.00 Mn |
| 7 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | - |
| 8 | Dexcom | 28.96 Bn | 27.84 Bn | 750.30 Mn | -124.60 Mn |
| 9 | Steris | 20.31 Bn | 19.88 Bn | 697.10 Mn | 123.50 Mn |
| 10 | Penumbra | 12.51 Bn | 11.90 Bn | 253.41 Mn | -5.54 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -5.54 Mn |
| Mar 31, 2026 | -5.54 Mn |
| Dec 31, 2025 | 6.82 Mn |
| Dec 31, 2025 | 6.82 Mn |
| Sep 30, 2025 | 8.45 Mn |
| Sep 30, 2025 | 8.45 Mn |
| Jun 30, 2025 | 4.78 Mn |
| Jun 30, 2025 | 4.78 Mn |
| Mar 31, 2025 | -543,000.00 |
| Mar 31, 2025 | -543,000.00 |
| Dec 31, 2024 | -3.23 Mn |
| Dec 31, 2024 | -3.23 Mn |
| Sep 30, 2024 | -25.39 Mn |
| Sep 30, 2024 | -25.39 Mn |
| Jun 30, 2024 | 10.49 Mn |
| Jun 30, 2024 | 10.49 Mn |
| Mar 31, 2024 | -8.46 Mn |
| Mar 31, 2024 | -8.46 Mn |
| Dec 31, 2023 | -6.34 Mn |
| Dec 31, 2023 | -6.34 Mn |